During the past decade, Instituto Oncológico Dr. Rosell. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Oncológico Dr. Rosell." #1 sponsor was "Genentech, Inc." with 1 trials, followed by "Instituto Oncológico Dr Rosell" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "NovoCure Ltd." with 1 trials sponsored and "Queen Mary University of London" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Oncológico Dr. Rosell." #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator, "Bioven Europe" with 1 trials as a collaborator and "MFAR" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Oncológico Dr. Rosell." are "Advanced Melanoma" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Pancreas Adenocarcinoma" (1 trials). Many other conditions were trialed in "Instituto Oncológico Dr. Rosell." in a lesser frequency.

Most popular intervention types in "Instituto Oncológico Dr. Rosell." are "Drug" (5 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AZD2014" (1 trials), "Cyclophosphamide" (1 trials), "EGF-PTI" (1 trials), "EGFR-TK Inhibitor" (1 trials) and "Everolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oncológico Dr. Rosell." are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto Oncológico Dr. Rosell.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Oncológico Dr. Rosell., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oncológico Dr. Rosell., 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".